EPA Releases First Agency-Wide PFAS Technology Strategy

On October 26, 2026, EPA released its first-ever agency-wide PFAS Technology, Evaluation, Coordination, and Harmonization (PFAS TECH) strategy. The strategy aims to address PFAS contamination through technology development and collaboration with federal partners, states, local leaders, and the private sector.

“This new effort will help catapult technology innovation on PFAS while supporting practical tools, funding, and technical assistance to benefit communities addressing local PFAS challenges,” EPA said in a press release.

The strategy, which is largely a compilation of existing and planned projects, has three overarching goals:

  1. Powering innovation in research and development. EPA will facilitate public-private partnerships to promote analytical method development and emerging technologies to remove PFAS from drinking water. EPA offices will also coordinate on organomineral and anaerobic digestion techniques for PFAS destruction and evaluate supercritical water oxidation, a process that EPA reports destroyed more than 99.99% of PFAS in firefighting foam at industrial scale.
  2. Demonstrating What’s Possible through Pilot-Scale Initiatives. EPA highlights partnerships with about 40 drinking water utilities to identify optimal treatment methods. The strategy also notes potential pilot projects with the Department of War and Department of Energy on emerging destruction technologies and a future framework for managing soil containing low concentrations of PFAS.
  3. Translating Progress into Practical Actions. EPA plans to publicly release a searchable tool for identifying appropriate destruction and disposal methods, called the PFAS Break the Bond Navigator. The tool will be updated on a rolling basis as EPA evaluates these technologies.

The strategy indicates that new R&D funding for PFAS destruction is coming through EPA’s Science to Achieve Results (STAR) grant program and Small Business Innovation Research programs. It also points to infrastructure law money for PFAS treatment, especially for small and rural systems.

According to the strategy, National Program Offices and Regional Offices will advance these actions over the next two years. EPA encourages interested parties to get involved by contacting PFASTECH@epa.gov.

Senate Bill Targets Toxic Substances in Single-Use Beverage Bottles

On September 24, 2026, Senator Peter Welch (D-VT) introduced S. 5525, the Banning Toxics from Plastic Bottles Act of 2026. If enacted, the bill would prohibit retailers from selling or distributing certain single-use beverage containers based on their plastic composition, coloration, or toxic substance content, including PFAS.

Prohibition

Section 3 of the bill, titled “Elimination of toxic substances and other substances that prevent recyclability in beverage containers,” would prohibit retailers, beginning two years after enactment, from selling, offering for sale, or distributing any single-use beverage container that:

  1. Is composed wholly or partially of polyethylene terephthalate glycol (PETG);
  2. Is opaque or pigmented a color other than transparent blue or transparent green;
  3. Contains polyethylene glycol (PEG); or
  4. Contains a “toxic substance.”

The prohibition is not limited to substances that are intentionally added.

Definition of “Toxic Substance”

The bill defines a toxic substance as any substance, mixture, or compound that may cause personal injury or disease to humans through ingestion, inhalation, or absorption through any body surface, or that may adversely impact the environment. The substance must also satisfy at least one of the five conditions set forth in Section 2(9)(B):

  1. Federal Reporting Requirements: The substance is subject to reporting requirements under the Emergency Planning and Community Right-to-Know Act (EPCRA), the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA), or Section 112(r) of the Clean Air Act (CAA).
  2. Health Hazards: Specified federal agencies—including EPA, OSHA, the CDC, and NIOSH—have established that the substance poses an acute or chronic health hazard, including developmental, reproductive, or endocrine effects.
  3. Latent Disease: EPA or NIOSH has recognized that the substance may increase the risk of developing a latent disease.
  4. Specified Chemicals and Classifications: The substance falls within certain chemical classes, including PFAS, orthophthalates, certain bisphenol compounds, halogenated or nanoscale flame retardants, UV-328, or chlorinated paraffins. This condition also includes substances designated under specified international conventions or carcinogenicity classifications.
  5. Other Identified Hazards: EPA determines that a federal, state, or international intergovernmental agency has identified the substance or chemical class as posing specified health or environmental hazards, including carcinogenicity, reproductive or developmental toxicity, persistence and bioaccumulation, or adverse impacts on air, soil, or water quality.

Notably, the bill does not define PFAS.

Penalties

Violations would be subject to fines of up to $50,000 per violation. Each product line of beverage containers would constitute a separate violation. Penalties collected under this provision would be deposited into a Local Clean Up of Plastics Fund, which would provide grants to local governments for solid waste and water system infrastructure improvements.

Status

The bill has been referred to the Senate Committee on Commerce, Science, and Transportation. Senator Welch introduced similar legislation last Congress, which did not advance out of committee.

Sens. Merkley (D-OR), Booker (D-NJ), Van Hollen (D-MD), and Sanders (I-VT) are original cosponsors.

New Mexico Appeals PFAS Labeling Injunction to the Tenth Circuit

New Mexico has appealed a preliminary injunction against the state’s far-reaching PFAS labeling requirement to the Tenth Circuit.

The notice of appeal, filed October 16, 2026, concerns only the portions of the district court’s order “holding that New Mexico’s PFAS label is unlikely to pass rational basis scrutiny under Zauderer v. Off. of Disciplinary Counsel, 471 U.S. 626 (1985).”

The District of New Mexico granted the preliminary injunction on September 21, 2026. Although the court preliminarily determined that the label was purely factual and uncontroversial under Zauderer, the court concluded that there was likely no reasonable connection between the labeling requirement and New Mexico’s asserted interests.

This conclusion rested on New Mexico’s characterization of the label as a consumer awareness disclosure rather than a warning. Specifically, the court questioned how the label furthers consumer awareness if it does not convey information about how PFAS may affect health or the environment.

“In characterizing the required label as a ‘consumer awareness label,’ and not a ‘warning label,’ Defendants destroy the connection between the purpose of the required disclosure – to promote consumer and environmental health – and the means employed to realize that purpose, which in other instances is achieved with a warning,” the order states.

If the preliminary injunction is lifted, the labeling requirement will take effect January 1, 2027, for all consumer products containing intentionally added PFAS except used products, pesticides, veterinary products, and medical devices and drugs.

In addition to the federal lawsuit, a state-court challenge to the rule is also ongoing.

What New Mexico May Argue on Appeal

A filing New Mexico submitted shortly after the injunction was granted may signal its appellate arguments.

On September 25, 2026, the state filed a submission in support of its motion to dismiss, in which it “respectfully ask[s] the Court to reconsider its reasoning” on whether the label is a reasonable fit. The state argues that the inquiry “does not hinge solely on what the label itself contains,” but instead “looks more broadly at what the label does.” This can be satisfied by common sense and logic, the filing contends.

According to the state, the label meets this standard because it allows consumers to avoid products containing PFAS, which “inherently furthers both the State’s public health and environmental protection interests.” In support, New Mexico points to record evidence that consumers are willing to pay more for PFAS-free products.

The state also argues that, under the district court’s reasoning, no ingredient disclosure could ever survive scrutiny without an accompanying warning. “This cannot be right,” the filing states, citing cases upholding labels for calorie counts and genetically engineered ingredients that did not include clarifying language about the underlying interest.

The case is Am. Chemistry Council v. Kenney, No. 1:26-cv-02130 (D.N.M.), filed July 1, 2026.

Update (October 21, 2026)

On October 20, 2026, the appeal was docketed as No. 26-2184.

NMED Seeks Public Input on New Mexico’s PFAS Exemptions

On October 8, 2026, the New Mexico Environment Department (NMED) held an in-person meeting to discuss whether certain products and materials should continue to be exempted from the state’s Per- and Poly-Fluoroalkyl Substances Protection Act.

The meeting follows the February 2026 passage of HJM 3, which directs NMED to report to the legislature “on the public health, environmental and economic risks of the exemptions codified in the” Act. The report must include recommendations on “whether such exemptions, such as the exemption for fluoropolymers, should be continued, modified or removed.”

HJM 3 characterizes the exemptions as “based on limited scientific literature regarding chemical degradation, environmental mobility and persistence, potential human exposure pathways and possible health impacts.”

The memorial also separately directs the New Mexico Environmental Improvement Board (EIB) to report on the Act’s implementation.

According to the meeting slides, NMED plans to present its interim findings to the Radioactive and Hazardous Materials Interim Committee on November 5, 2026. NMED is accepting public comments on the exemptions through December 31, 2026. The report to the legislature is due August 1, 2027.

NMED also held a webinar on HJM 3 on August 18, 2026.

Legal Background

Enacted in 2025, the Per- and Poly-Fluoroalkyl Substances Protection Act imposes phased prohibitions on products containing intentionally added PFAS. The Act also requires manufacturers to report products containing intentionally added PFAS to NMED by January 1, 2027. However, sixteen categories of products and materials—including fluoropolymers, used products, medical devices, semiconductors, certain refrigerants, and motor vehicles—are exempt from these requirements.

Earlier this year, EIB adopted regulations proposed by NMED to implement the statute. The regulations also establish a near-universal PFAS labeling requirement for consumer products, effective January 1, 2027. The labeling requirement applies even to products covered by the statute’s exemptions, subject to limited exceptions for used products, pesticides, veterinary products, medical devices, and drugs.

The District of New Mexico has since preliminarily blocked the labeling mandate on First Amendment grounds. A separate state-court challenge to the rule is also ongoing.

Focus on the Fluoropolymer Exemption

Much of the discussion surrounding the statutory exemptions has focused on fluoropolymers, a subclass of PFAS consisting of substances with polymeric per- or polyfluorinated carbon backbones. One of the best-known fluoropolymers is polytetrafluoroethylene (PTFE), also known by the brand name Teflon. PTFE is used in nonstick cookware, electronics, industrial equipment, medical devices, and numerous other applications.

The statutory exemption for fluoropolymers also encompasses a separate but related PFAS subclass known as polymeric perfluoropolyethers.

Fluoropolymers are the only exemption specifically identified in HJM 3. The memorial directs NMED to consider whether the exemptions, “such as the exemption for fluoropolymers,” should be modified. It also states that “additional health and environmental studies are needed to understand more fully the toxicological profiles, exposure risks and public health implications of fluoropolymers.”

Several plaintiffs in the federal litigation challenging the regulations implementing the Act have submitted comments urging NMED to recommend continuing the fluoropolymer exemption. They argue that fluoropolymers do not present health or environmental risks, serve critical or irreplaceable functions, and have been treated separately from other PFAS in other jurisdictions.

For more on New Mexico’s regulation of PFAS in products, visit our NM PFAS archive.

California Scales Back Pesticide PFAS Bill, Enacts Disclosure-Only Law

On September 27, 2026, California enacted legislation requiring the Department of Pesticide Regulation (DPR) to disclose the presence of PFAS in pesticides, defined as substances containing at least one fully fluorinated carbon atom.

The chaptered version of AB 1603 is far narrower than an earlier iteration. As amended in March 2026, the bill would have prohibited the registration or re-registration of pesticides with intentionally added PFAS, imposed labeling requirements, and phased out PFAS in pesticides altogether. More on those proposed requirements can be found in a previous post.

As chaptered, the law instead requires DPR to:

  1. Indicate if a pesticide contains PFAS ingredients in its pesticide use reporting database and add PFAS as a category of interest in the database;
  2. Include PFAS trends in its annual pesticide use report and other relevant reporting documents; and
  3. Publish a list of all registered pesticides containing PFAS on its website and submit it to local officials.

The disclosures apply beyond active ingredients. Specifically, they apply to PFAS intentionally added to a pesticide as active, adjuvant, or inert ingredients.

Notably, despite its narrowed scope, the legislation declares the Legislature’s intent to “[b]egin phasing out the use of PFAS pesticides and take additional steps to address other PFAS in pesticides.”

The database update is required on or before January 1, 2028, or the posting of the pesticide use reporting database containing 2026 data, whichever comes first, and annually thereafter. The list of registered pesticides containing PFAS is also due January 1, 2028, and must be updated within 60 days of the registration of a new pesticide containing PFAS.

Connecticut Issues Guidance on PFAS Labeling and Notification Requirements

Last month, the Connecticut Department of Energy and Environmental Protection (DEEP) released guidance on the state’s PFAS product restrictions, including the labeling and notification requirements that took effect for twelve product categories on July 1, 2026.

The guidance clarifies that the notification and labeling requirements apply to products manufactured before the July 1 effective date, despite the statute’s exemption for products manufactured prior to an applicable prohibition. This is because the notification and labeling requirements “are requirements, not prohibitions,” DEEP states.

“Manufacturers may direct retailers to apply a label for products that are already in their inventory,” the guidance adds.

DEEP also states that it is not issuing compliance extensions. “If your product is out of compliance, please submit the notification and begin labeling products immediately,” it says.

Other provisions of the guidance clarify that:

  • For online sales, the label disclosure must be provided on the same webpage as the product, without requiring the consumer to click to another webpage;
  • Labels may be affixed to the packaging of a product or the product itself, so long as they are clearly visible prior to sale;
  • Products subject to federal labeling requirements, such as those arising under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), are not subject to the state’s labeling requirement; and
  • Because “no person” may sell noncompliant products, retailers are required to stop offering any product that DEEP determines to be noncompliant.

The guidance is posted on DEEP’s PFAS in products webpage.

Covered Product Categories

The twelve product categories subject to the July 1, 2026, labeling and notification deadline are:

  • Apparel (excluding outdoor apparel for severe wet conditions)
  • Carpets or rugs
  • Cleaning products
  • Cookware
  • Cosmetic products
  • Dental floss
  • Fabric treatments
  • Children’s products
  • Menstruation products
  • Textile furnishings
  • Ski wax
  • Upholstered furniture

Beginning January 1, 2028, Connecticut will prohibit the sale or distribution of products in the categories listed above—as well as outdoor apparel for severe wet conditions and turnout gear—if they contain intentionally added PFAS. Outdoor apparel for severe wet conditions and turnout gear are subject to slightly different disclosure requirements, which took effect January 1, 2026.

DEEP has approved multiple label disclosure options. Most recently, it approved a symbol consisting of an outline of an Erlenmeyer flask with the word “PFAS” inside—the same design required under New Mexico’s near-universal PFAS labeling requirement, which a federal court has preliminarily blocked.

More information on the labeling and notification requirements can be found in a previous post.

Court Dismisses “Organic” Claims Against Scotts Miracle-Gro Over PFAS Allegations

On September 11, 2026, the Southern District of California granted The Scotts Company’s motion to dismiss a lawsuit challenging “organic” representations on soil and fertilizer products allegedly containing PFAS.

According to the court, the plaintiffs allege that Scotts engaged in false advertising by representing certain Miracle-Gro soil and fertilizer products as “organic” even though testing allegedly showed that the products contained PFAS, including PFOA and PFOS. They also argue that Scotts failed to disclose the presence of PFAS and represented that the products were safe for use on edible plants and residential gardens.

The plaintiffs allege that they relied on the “organic” representations when purchasing the Miracle-Gro products and would not have purchased the products, or would have paid less for them, had they known the products contained PFAS.

“Organic” Claims and Safe Harbor

The court noted that California’s safe harbor doctrine generally prevents plaintiffs from bringing unfair competition claims based on conduct that is expressly permitted by law.

Here, the court took judicial notice of the California Department of Food and Agriculture’s (CDFA’s) lists of Registered Organic Input Material (OIM) products. The court noted that the products at issue appeared on the OIM lists. The court further explained that, under California regulations, products registered as OIM are permitted to use the term “organic” on their labels.

As a result, the court concluded that Scotts’ use of the term “organic” was expressly permitted under California’s regulatory scheme and that the plaintiffs could not use California consumer-protection laws to challenge conduct that California regulations specifically permitted. The court dismissed the plaintiffs’ claims under California’s Unfair Competition Law (UCL), False Advertising Law (FAL), and Consumer Legal Remedies Act (CLRA) without leave to amend because it concluded that the safe harbor doctrine would continue to bar them.

Acknowledging a split in authority over whether the safe harbor spans beyond consumer protection statutes, the court held that it should, because it would otherwise allow plaintiffs to circumvent the doctrine by framing consumer protection claims as common law causes of action. Accordingly, the court also dismissed the plaintiffs’ breach of express warranty, breach of implied warranty, and unjust enrichment claims.

PFAS Omission and Other Misrepresentation Claims

The court reached a different conclusion regarding the plaintiffs’ allegation that Scotts failed to disclose the presence of PFAS. The court found that, because California law does not expressly permit Scotts to omit a PFAS disclosure, the safe harbor doctrine did not automatically bar this theory.

However, the court concluded that the plaintiffs did not adequately plead their omission claim. As the court explained, a partial-omission theory generally requires an existing representation that is true but misleading because important information was left out. According to the court, the plaintiffs instead alleged that Scotts’ representations that the products were “organic” and safe for use on edible plants were themselves false. The court therefore found that those allegations could not support a partial-omission theory as pleaded.

The plaintiffs’ separate misrepresentation theory, that the product packaging suggested the products were safe for use on edible plants, also failed. According to the court, the plaintiffs alleged that they relied on the products being labeled “organic” when deciding to purchase them, but did not allege that they relied on the imagery or representations concerning use on edible plants. Thus, the court concluded that they did not adequately plead reliance on that alleged misrepresentation.

Because the court found that the plaintiffs may be able to correct these deficiencies with additional facts or theories, the court dismissed the alternative misrepresentation and omission claims with leave to amend. The court gave the plaintiffs 30 days from the September 11 order to file an amended complaint.

Standing for Unpurchased and Untested Products

Scotts also argued that the plaintiffs lacked standing to assert claims concerning Miracle-Gro products they had not personally purchased or tested. The court noted that there is no controlling Ninth Circuit authority on whether class-action plaintiffs may assert claims based on products they did not purchase. However, the court followed what it described as the “prevailing view” in the Ninth Circuit: plaintiffs may pursue claims involving unpurchased products where the products and alleged misrepresentations are substantially similar.

The court found that standard satisfied for the products identified in the complaint. Among other similarities, the products were Miracle-Gro soil and fertilizer products represented as organic, marketed as safe for use on edible plants, alleged to contain PFAS, and alleged to omit disclosure of PFAS. The plaintiffs independently tested seven products, including the products they purchased, and all seven contained PFOS, while six contained both PFOS and PFOA. Based on those allegations, the court concluded that the plaintiffs had standing to pursue claims concerning the identified products, including products they had not personally purchased or tested.

The court did not, however, extend standing to unidentified products. Although the plaintiffs sought to challenge all Scotts Miracle-Gro soil and fertilizer products represented as organic, the court limited their claims to the products specifically identified in the complaint.

The case is Calcagno v. Scotts Co. LLC, No. 3:25-cv-02661 (S.D. Cal.).

Philip A. Moffat Quoted in Chemical Watch Article on NM PFAS Litigation

On September 30, 2026, Verdant Law attorney Philip A. Moffat was quoted in a Chemical Watch article titled “New Mexico Faces PFAS Disclosure Dilemma After Court Halts Labelling Scheme.”

Mr. Moffat discussed New Mexico’s options following a federal court’s issuance of a preliminary injunction in litigation challenging the state’s far-reaching PFAS labeling requirement. He also addressed the status of a separate state-court challenge to the labeling mandate.

A copy of the article is available here.

Federal Court Blocks New Mexico PFAS Labeling Rule

A federal judge has issued a preliminary injunction against New Mexico’s far-reaching PFAS labeling requirements for consumer products, finding that the trade associations challenging the rules are likely to prevail on their First Amendment claim. The court’s order turns on its determination that the labeling mandate is not a “reasonable fit” for the state’s asserted interests.

Issued September 16, 2026, the injunction bars enforcement of the labeling mandate in its entirety while the litigation proceeds—less than four months before the requirements were set to take effect.

Regulatory and Legal Background

New Mexico promulgated the PFAS labeling mandate in May 2026. If allowed to take effect, the rules would require all consumer products manufactured for sale or distribution in the state that contain intentionally added PFAS to bear a PFAS label after January 1, 2027. The required label consists of the term “PFAS” within an Erlenmeyer flask pictogram. Only used products and certain products subject to federal regulation, like pesticides and drugs, are exempt.

In July, the plaintiffs—which include the American Chemistry Council, Alliance for Automotive Innovation, American Coatings Association, National Association of Manufacturers, and several other industry groups—filed suit in the District of New Mexico. Their arguments revolve around which type of First Amendment scrutiny should apply to the labeling mandate.

While government-compelled speech is generally subject to heightened scrutiny, a lesser form of scrutiny applies to certain types of compelled commercial disclosures under Zauderer v. Office of Disciplinary Counsel. As discussed in a previous post, the plaintiffs argue that Zauderer does not apply and that the labeling mandate should therefore be subject to heightened scrutiny.

The Preliminary Injunction

Analyzing the label under Zauderer, the court first found that the required disclosure was likely to be purely factual and uncontroversial. However, the court then preliminarily determined that there was no reasonable connection between the labeling requirement and New Mexico’s asserted interests, making Zauderer inapplicable.

New Mexico asserted interests in protecting consumer health and safety, protecting the environment, and providing relevant information about the manufacturing process to consumers. In response to the plaintiffs’ argument that the label is not purely factual because it misleadingly communicates hazard, New Mexico stressed that the label is not a warning. Instead, the state argued, the label merely promotes consumer awareness of PFAS.

This proved to be the state’s undoing. “In characterizing the required label as a ‘consumer awareness label,’ and not a ‘warning label,’ Defendants destroy the connection between the purpose of the required disclosure – to promote consumer and environmental health – and the means employed to realize that purpose, which in other instances is achieved with a warning,” the order states.

“A label that conveys no information cannot, be ‘inextricably intertwined’ with the goal of reducing the health and environmental impact of PFAS for the label does not provide any advice or information about PFAS,” the order continues.

In the court’s view, New Mexico’s characterization of the label makes its goal more akin to addressing “consumer curiosity.” The court noted that other courts have found consumer curiosity to be an insufficient basis for compelled labeling.

The court also observed that New Mexico appears to want the label to operate as a warning, pointing to statements in the state’s expert declarations and on its website characterizing the label as a warning. “However, the Regulation cannot simultaneously, as Schrödinger would have it, be merely a consumer awareness label and not a warning label, and if it is a consumer awareness label it serves to promote consumer curiosity about the contents of various products,” the order states.

Because the court found no reasonable fit between the disclosure requirement and the state’s asserted interests, it concluded that the mandate could not survive heightened scrutiny either.

The case is Am. Chemistry Council v. Kenney, No. 1:26-cv-2130 (D.N.M.), filed July 1, 2026.

D.C. Circuit Upholds EPA’s CERCLA Designation of PFOA and PFOS

The D.C. Circuit has upheld EPA’s designation of two PFAS, perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS), as hazardous substances under the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA).  In Chamber of Commerce v. EPA, decided August 18, 2026, the court denied every petition challenging the designation, leaving the 2024 rule in place.

What the Court Decided

Industry petitioners, led by the U.S. Chamber of Commerce and joined by chemical, fuel, waste, recycling, construction, and paper trade associations, raised three lines of attack: (1) that EPA misread CERCLA’s “may present substantial danger” standard; (2) that its cost-benefit analysis violated the Administrative Procedure Act’s notice requirement and was arbitrary and capricious; and (3) that regulating amid scientific and economic uncertainty was itself unreasonable.  The panel rejected all three.

Starting with the standard for designation, 42 U.S.C. § 9602(a) directs EPA to designate as hazardous those substances that, when released into the environment, “may present substantial danger to the public health or welfare or the environment.”  Petitioners read that phrase to require a finding that harm will occur on release.  Interpreting the statute de novo and without deference to EPA under Loper Bright Enterprises v. Raimondo, the court disagreed.  “May” denotes possibility, not certainty, and the statute directs EPA to forecast the risk of harm at the time a substance is released, the court held.  The phrase “substantial danger” means that the risk of harm must be serious and real, not hypothesized, which the court said answers the worry that EPA’s reading would let the agency reach something as innocuous as table salt.  Requiring absolute certainty about every release, the court added, would paralyze a statute Congress designed to act on scientific probabilities.

The court rejected two related theories within the same challenge.  First, it declined to read an inflexible hierarchy into CERCLA under which “hazardous substances” must clear a higher bar than “pollutants or contaminants.”  The two are separate designation regimes, the court held, and a substance may begin as a pollutant or contaminant and later be designated a hazardous substance as the science develops.  Second, the court found no nondelegation or void-for-vagueness problem.  Tying EPA’s authority to scientific findings under a public-health standard supplies the “intelligible principle” the nondelegation doctrine requires, the decision states, and the prior regulation of PFOA and PFOS under CERCLA gave regulated parties fair notice that they could be listed.

On the notice challenge, the court held that EPA’s Regulatory Impact Analysis was a “logical outgrowth” of the earlier Economic Assessment, so the additional cost data introduced in the final rule required no fresh comment round.  Notably, the court did not decide whether CERCLA requires EPA to weigh costs in a designation at all.  EPA assumed it must, and the panel assumed the same without deciding, which leaves that question open for a future challenge.

As for regulating amid uncertainty, the court held that EPA acted reasonably in designating PFOA and PFOS despite acknowledged gaps in what it knows about where the chemicals are, what cleanup will cost, and the rule’s downstream effects.  The decisive point was that designation is only the first of many steps before liability attaches.  A long sequence of contingent regulatory actions, together with CERCLA’s statutory limits on liability, stands between listing a substance and any party actually bearing cleanup costs.  Accordingly, the court concluded that EPA’s choice to regulate now rather than wait for certainty was not arbitrary and capricious.

Why It Matters

The designation, effective July 8, 2024, was EPA’s first use of 42 U.S.C. § 9602(a) to list a substance directly, rather than by reference to another environmental statute.  Its practical consequences are now in force: releases of one pound or more of PFOA or PFOS in a 24-hour period trigger reporting obligations, federal property transfers carry notice duties, and most significantly, responsible parties face CERCLA’s strict, joint-and-several liability and cost-recovery regime.

The ruling reaches well beyond PFAS manufacturers.  Waste management, recycling, construction, and other “passive receivers” that handled PFOA- and PFOS-containing materials without making them may now sit within the liability chain.  As the court stressed in rejecting the uncertainty challenge, though, listing is not the same as liability: CERCLA’s defenses, including its act-of-God, third-party, de minimis, de micromis, and innocent-landowner provisions, continue to limit who ultimately pays.

What to Watch

The decision is recent, and the deadlines for a petition for rehearing en banc or a petition for certiorari have not yet run, so the litigation may not be over.

Several aspects of the ruling bear on future CERCLA designations.  Because the court reviewed EPA’s reading de novo and still upheld it, the agency’s designation authority now rests on the statute’s best reading rather than on judicial deference, a firmer footing in the wake of Loper Bright.  EPA committed to notice-and-comment rulemaking before updating this designation, and it has said it intends to develop a broader framework for § 9602(a) designations generally, though the scope and timing of any such rulemaking remain to be seen.  And because the court left open whether cost must be weighed in a designation at all, that question is likely to return as EPA considers additional substances.

For background on the agency’s decision to defend the rule, see our previous post on the litigation.

The case is Chamber of Commerce v. EPA, No. 24-1193 (D.C. Cir.), filed June 10, 2024.